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Abstract
Background: We reviewed our institutional experience in the diagnosis and management of pediatric thyroid
nodules and well-differentiated thyroid carcinoma (WDTC), highlighting the unique challenges in this population.
Methods: IRB approved retrospective chart review was conducted on patients who underwent fine needle
aspiration (FNA) or thyroid surgery from 1/1/2001 to 12/31/2010 at Rady Children’s Hospital San Diego, a tertiary
referral center in Southern California. Patients thus identified who completed their initial treatment at our institution
were included.
Results: Total of 79 subjects qualified; 20 had FNA only, and 59 underwent thyroid surgery. Of the latter, 29 had
benign histology and 30 had WDTC. Average age was 14.5 years with a female: male ratio of 4:1 for WDTC versus
1.6:1 for benign nodules. When compared to final pathology, malignancy rate was high in indeterminate FNA cytology
at 60 %. Neck metastasis was noted in 40 % and pulmonary spread in 10 % of patients. There was a 2.75 fold increase
in malignant cases (n = 22) treated during 2006–2010 compared to 2001–2005 (n = 8) with more advanced disease at
initial presentation. Ninety percent of WDTC patients received adjuvant I-131 treatment with an initial average dose of
132.4 mCi. Despite aggressive initial presentation, 26/30 patients had no evidence of disease at last follow-up, with an
average length of 40.3 months.
Conclusions: In recent years, we are managing significantly more WDTC cases at our institution with advanced disease
at the onset. Malignancy rate on indeterminate cytology is higher than reported in adults with an overall high rate of
malignancy in thyroid nodules removed in this cohort. Disease control and short-term outcome is still excellent. The
recently published pediatric guidelines for WDTC will further standardize management.
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Background
Well-differentiated thyroid carcinoma (WDTC) is rela-
tively uncommon in the pediatric population when com-
pared to adults, with those < 20 years old comprising
only 1.8 % of all new cases of thyroid malignancy [1].
However, it is not unusual in adolescents and may repre-
sent up to 11 % of all new cases of cancer reported in
2014 between the age of 15 and 19 according to the
American Cancer Society [2]. Until the recently pub-
lished pediatric guidelines [3], the management of
WDTC in children largely extrapolated from adult
guidelines published by the American Thyroid Associ-
ation (ATA) [4]. However, clinical presentation and
tumor behavior may differ significantly in children, with
larger volume, earlier involvement of the capsule and
more extensive lymph node involvement [5, 6]. The ob-
ject of this study is to describe the patient characteristics
of pediatric thyroid nodules and WDTC presented to
our institution and our experience in the diagnosis and
management of WDTC over a 10-year period. This case
series serves to demonstrate some of the challenges in
the pediatric population.* Correspondence: wjiang@rchsd.org
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We obtained institutional review board approval for the
retrospective review of all patients who underwent thy-
roid fine needle aspiration (FNA) or thyroid surgery
from 1/1/2001 to 12/31/2010 with age ranging from
birth to 21 years. A total of 83 patients with thyroid
nodules were treated at Rady Children’s Hospital San
Diego (RCHSD). One patient with medullary thyroid
carcinoma was excluded from the analysis and three pa-
tients were excluded due to either previous treatment
elsewhere or transfer of care to another institution after
the initial biopsy.
Pre-operative imaging and surgical management
All patients had imaging prior to surgery and all had
Ultrasound (US) of the thyroid and neck preoperatively
as recommended by the ATA guideline [3]. Seven pa-
tients also had Magnetic Resonance Imaging (MRI) for
evaluation of regional lymph nodes after the initial US
although none of the MRIs revealed any additional infor-
mation or resulted in change in surgical recommenda-
tions. Four patients who presented with bulky neck
disease also underwent chest Computed Tomography
(CT) without contrast to evaluate for lung metastasis
which were all negative. If the thyroid FNA was positive
for malignancy, patients underwent total thyroidectomy
as the initial surgical procedure. Any patient with clinic-
ally palpable cervical lymphadenopathy on physical exam
and/or radiologically positive lymph nodes underwent
therapeutic comprehensive neck dissection in the in-
volved compartment. Criteria used to define clinically
palpable cervical lymphadenopathy included increased
size, rounded shape, firmness and poor mobility on
physical examination. Suspicious lymph nodes on US
had one or more of the following characteristics: in-
creased size, rounded shape, loss of central hilum, cystic
appearance, peripheral vascularity on Doppler imaging
and micro-calcifications [7]. FNA of cervical lymph
nodes were not performed during this study period.
Prophylactic central compartment (level VI) neck dissec-
tions were not routinely performed at this institution.
Clinical staging
The sixth edition of the AJCC/UICC TNM classification
was used to determine the tumor (T), nodal (N), and
distant metastasis (M) stages [8]. Of the 30 patients with
malignancy, 27 (90 %) were defined as stage I, and 3
(10 %) were classified as stage II with pulmonary
metastasis.
Follow-up
TSH suppression therapy was administered to all patients
with a target of TSH < 0.1mIU/L. Patients were followed
using serum thyroglobulin (Tg), neck US and whole body
scan (WBS). A patient was considered free of disease at
follow-up if basal Tg was non-detectable <0.2 ng/mL as
well as stimulated Tg <1 ng/mL (using either T4 with-
drawal or Thyrogen), and both US and whole body scan
were negative. Prior to 2013, all Tg levels were measured
by immunometric assays which maybe inaccurate in the
presence of Tg antibodies. Since 2013, for patients with
positive Tg antibodies, a new liquid chromatography-
tandem mass spectrometry (LC-MS/MS) method [9]
(Quest Diagnostics, San Juan Capistrano, CA) has been
used to measure serum Tg.
Statistical analysis
When comparing age differences between FNA-only, be-
nign and malignant group, a one-way Analysis of Variance
(ANOVA) was performed and when gender distributions
were compared among the three groups, a Pearson’s chi-
square test was performed. The differences were consid-
ered statistically significant with p-value <0.05.
Results
Fine needle aspiration
Among the 79 patients who qualified for the study, 20
had FNA-only without subsequent surgery and 59
underwent thyroid surgery. Patient characteristics and
tumor sizes are shown in Table 1. Of the 20 FNA-only
patients, six samples were initially non-diagnostic, all
performed under ultrasound guidance. Of these, two pa-
tients had subsequent FNA that showed benign cytology.
The other four patients did not undergo subsequent re-
peat biopsy; two had cystic nodules that resolved after
aspiration, and two patients were lost to follow-up after
the initial FNA. The cytology of the remaining 14 samples
was benign based on the Bethesda classification, including:
eight benign nodules, three colloid nodules and three
lymphocytic thyroiditis. The average follow-up for this
group was 21.4 months with no documented changes in
nodule size.
Among the 59 patients who underwent thyroid sur-
gery, 37 (62.7 %) underwent FNA prior to surgery. Of
these, two cases were performed at another institution
and were excluded in the FNA analysis. In the remaining
35, the rate of non-diagnostic specimen was 14.3 % (5/
35). Indeterminate cytology includes the categories of
Atypia of Undetermined Significance (AUS)/Follicular
Lesion of Undetermined Significance (FLUS), Follicular
Neoplasm and Suspicious for Malignancy. Table 2 shows
the finding of FNA when compared to final pathology.
Among the FNA samples obtained prior to the publica-
tion of the Bethesda staging system in 2008, there was
one case of “atypical cytology” that was reassigned as
AUS, two cases of “suspicious for malignancy” and two
cases of “follicular neoplasm” that remained in the same
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corresponding categories. Overall malignancy rate of all
biopsied nodules including FNA-only patients was 40 %
(22/55). In the benign cytology category, three patients
were diagnosed with malignancy on final pathology; one
patient had a 1.7 x 1.4 x 2.5 complex nodule, one had a
4.7 x 4.2 x 2.7 cm solid nodule and the third patient had
3.8 x 2.8 x 2cm solid nodule.
As a quality control measure, all cytology specimens
since 2007 were sent to adult cytologists at University of
California, San Diego (UCSD) for review prior to results
being released. A total of 24 FNA cytology specimens
were sent for second-opinion consultation. Among these,
only two samples (8.3 %) had discordant cytological read-
ing. One sample was read as FLUS at RCHSD and benign
at UCSD with final pathology being “Hurthle cell aden-
oma.” Another sample was read as “suspicious for malig-
nancy” at RCHSD and “AUS” at UCSD with final
pathology being follicular adenoma.
Surgery and surgical pathology
Among the 59 patients who underwent thyroid surgery,
the group was evenly divided with 29 patients having be-
nign pathology and 30 patients with WDTC. In the be-
nign group, 25 underwent thyroid lobectomy and four
patients underwent total thyroidectomy for large multi-
nodular goiters with compressive symptomatology. For
the patients with WDTC, 19 underwent total thyroidec-
tomy at the initial surgery, and 11 had lobectomy
followed by completion thyroidectomy once final path-
ology confirmed malignancy. Frozen sections were not
routinely used for primary tumor given that a large per-
centage of tumors with indeterminate cytology were fol-
licular neoplasms where frozen sections are not helpful
determining vascular or capsular invasion. Among the
WDTC, the majority 18/30 (60 %) were classic papillary
carcinoma, 8/30 (26.7 %) were follicular variant of papil-
lary carcinoma and 4/30 (13.3 %) were follicular
carcinoma.
The mean age at presentation was 13.9 ± 3.7 years in
all patients who underwent thyroid surgery, with a range
of 4 to 21. There was no statistical difference in the
mean age between the benign and malignant groups
(13.2 and 14.6 years respectively) (Table 1). When gen-
der differences were analyzed, there was a female pre-
dominance in the WDTC group with a female to male
ratio of 4:1 (24:6) when compared to the benign path-
ology group 1.6:1 (18:11). However this was not statisti-
cally significant. With respect to ethnicity, in our study
Table 2 Thyroid cytology with implied risk of malignancy: comparing institutional pediatric data to established adult literature
Diagnostic category % FNA (n) Number of malignancies Risk of malignancy RCHSD % Risk of malignancy Bethesda %
Non-diagnostic 14.3 (5) 1 20 1–4
Benign 17.1 (6) 3 50 0–3
AUS/FLUS 8.6 (3) 1 33 5–15
Follicular neoplasm 20 (7) 4 57 15–30
Suspicious for malignancy 14.3 (5) 4 80 60–75
Malignant 25.7 (9) 9 100 97–99
Final pathology had 62.9 % (22/35) overall malignancy rate out of total of 35 FNAs in the surgical group
FNA Fine-needle aspiration, AUS Atypia of Undetermined Significance, FLUS Follicular Lesion of Undetermined Significance
Table 1 Patient characteristics
Characteristic FNA-only Benign Malignant
Number of Pt. 20 29 30
Age at diagnosis (years)
Mean (SD) [range] 14.4(3.4) [8–20] 13.2 (3.6) [4–20] 14.6(2.8) [9–21] p = 0.24
Gender
Male 3 11 6
Female 17 18 24
Tumor size, cm p = 0.74
< 2 14 15 10
2–4 5 12 12
> 4 1 2 8
US characteristics
Cystic components 4 (20 %) 13 (44.8 %) 3 (10 %)
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population, 63 % of the patients were Hispanics by self-
reporting with no significant differences between benign
(52 %) and malignant (73 %) groups. Patients were from
over 26 zip code areas throughout San Diego County
and neighboring counties, and we did not notice any ob-
vious geographic clustering.
Overall, 40 % of the patients had regional metastasis
determined by positive nodal disease on final pathology
and 10 % had pulmonary metastasis as evident by diffuse
uptake in the lung on whole body scan (WBS) after the
initial radioiodine (I-131) treatment. Of the 30 patients
with malignancy, 27 (90 %) were defined as stage I, and
3 (10 %) were classified as stage II with pulmonary me-
tastasis. Figure 1 illustrates the TNM Staging of patients
with WDTC. All three patients with pulmonary metasta-
sis had large primary tumors and bulky lateral neck N1b
disease consistent with the pattern of metastatic spread
for papillary thyroid carcinoma [10]. Forty percent (12/
30) of the patients underwent central and/or lateral
compartment neck dissection. Seven out of 30 patients
underwent both central neck dissection and selective lat-
eral compartment neck dissection most commonly in-
volving level II-IV. Five additional patients underwent
central neck dissections only. All seven patients who had
N1b disease presented with bulky palpable neck mass at
the initial clinical exam ranging from 1.5 to 4 cm that
was confirmed with both US and MRI prior to undergo-
ing comprehensive lateral compartment selective neck
dissections. These were felt to be obvious metastatic dis-
ease; therefore, FNA was not performed pre-operatively.
There was also bulky central neck disease in these seven
patients, consistent with the pattern of spread for papil-
lary thyroid carcinoma. In the absence of lateral neck
disease, central neck dissections were performed based
on the surgeon’s determination of pathologic nodal dis-
ease intra-operatively with judicious use of frozen sec-
tions. Prophylactic central compartment (level VI) or
lateral neck dissections were not routinely performed at
this institution. One patient was included in node posi-
tive staging group with a microscopic focus of papillary
carcinoma in a lymph node incidentally removed with
total thyroidectomy specimen without formal neck dis-
section. When neck dissections were performed, only
one case was negative for nodal metastasis in the central
compartment due to the discrepancy between the pre-
operative FNA of papillary thyroid carcinoma and the
final pathology of follicular carcinoma, which rarely
metastasize to regional lymph nodes.
Postoperative complications
With regards to surgical complications, two of the 59 pa-
tients who underwent thyroidectomy had unilateral vocal
cord paralysis (3.4 %). One was anticipated due to gross
extra-capsular spread with direct tumor involvement (T4)
of the recurrent laryngeal nerve at the time of surgery.
The same patient also suffered permanent hypoparathyr-
oidism as a consequence of extensive central neck involve-
ment, the only patient in the study population to develop
that complication (1.7 %).
Radioactive iodine and follow-up
Post-operatively, the majority of the patients with
WDTC (90 %) were treated with radioactive iodine (I-
131), with an average initial dose of 132.4 mCi. Prior to
2008 and the capability to administer I-131 on an out-
patient basis at RCHSD, all patients were referred to
outside institutions for radioiodine therapy. Three pa-
tients received additional I-131 due to persistently ele-
vated Tg from pulmonary disease after the initial
treatment. One patient with T4N1b disease required re-
operation due to persistent disease 6 months after the
initial total thyroidectomy and ipsilateral central and lat-
eral neck dissections. She had persistently elevated Tg
3 months after 169 mCi of I-131 treatment and US re-
vealed a para-tracheal mass and contralateral suspicious
central compartment lymph nodes. She had re-operation
in the thyroid bed and contralateral central neck dissec-
tion at the same time that was not addressed at the ini-
tial surgery.
The average follow-up was 40.3 ± 24.9 months for pa-
tients with WDTC with a range of 4 to 98 months. In the
entire cohort, there was no regional nodal recurrence in
the operated compartment at the last follow-up. Despite
aggressive presentation, 26/30 patients had no evidence of
disease by non-detectable basal and stimulated Tg, US
and/or WBS at the time of the last follow-up.
Discussion
WDTC is relatively uncommon in the pediatric popula-
tion; however the overall incidence is rising in recent
years. The reported incidence was 0.54 per 100,000 in
2004 according to the Surveillance, Epidemiology and
End Results (SEER) database [5] with more recent data
showing the average age–adjusted annual incidence
(2008 to 2011) has risen to 0.89 per 100,000 persons in
< 20 years old group. In this series, the mean age of
presentation is 14.6 for WDTC which is slightly younger
than the peak incidence between 15 to 19 reported in
the adolescent age group [5]. The female predominance
(4:1) found in our study population is in agreement with
the overall national incidence of thyroid carcinoma with
age-adjusted incidence of 0.89 cases per 100,000 in fe-
males and 0.20 cases per 100,000 in males [1]. Among
the patients with WDTC, the most common histologic
type is classic papillary carcinoma 18/30 (60 %), followed
by follicular variant of papillary carcinoma 8/30 (26.7 %)
and follicular carcinoma 4/30 (13.3 %). This is also
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Fig. 1 TNM Staging of WDTC in 30 consecutive patients from 2001 to 2010. The sixth edition of the AJCC/UICC TNM classification was used to
determine the tumor (T) stage, nodal (N) stage, and distant metastasis (M) stage
Jiang et al. International Journal of Pediatric Endocrinology  (2016) 2016:1 Page 5 of 8
consistent with published literature with majority of
pediatric WDTC being papillary pathology [10].
Our institution is located in Southern California north
of the border between the United States and Mexico with
45 % Hispanic children in San Diego County according to
census data from 2008 to 2012 [11]. In our study popula-
tion this proportion is even higher at 63 %. The high
percentage of Hispanics makes our study population
somewhat unique and may affect the generalizability of
the study result in other geographic areas with different
demographics.
In the FNA-only group, the non-diagnostic rate is high
at 30 % compared to the surgical group of 14.3 %. The
follow-up of these patients was not always adequate, due
to age and relocation. In order to address the high non-
diagnostic rate, we have instituted mandatory adequacy
testing at the time of the FNA procedure in 2012 and
have reduced our overall non-diagnostic rate to 0 % for
the last 2 years.
In the surgical group, FNA was performed on the pri-
mary thyroid nodule in majority (62.7 %) of the patients
prior to surgery. With the recent availability of Tg assay
from FNA washout at our hospital, we are starting to in-
corporate the recommendation of obtaining cytological
confirmation of metastatic disease to lymph nodes in the
lateral neck prior to surgery according to the 2015
pediatric guidelines [3]. Most of the patients who were
not offered FNA prior to surgery were from earlier years
when the surgical staffs at our institution performed pri-
mary excisional biopsy or lobectomy for tissue diagnosis
due to concern for malignancy and accuracy of pediatric
FNA. Prior to 2007, thyroid surgeries were performed by
surgeons from various disciplines including pediatric
surgery, pediatric otolaryngology and adult endocrine
surgery who came to RCHSD occasionally, and each sur-
geon only performed 1–2 procedures a year at our insti-
tution. Since 2007, the evaluation at our institution has
been streamlined and standardized. A single surgeon
performed 90 % of all thyroid surgeries, and all patients
with thyroid nodules were offered FNA when indicated
prior to surgery. A formal multi-disciplinary pediatric
thyroid tumor board was established during the later
part of the study period where imaging, FNA results,
surgical planning as well as adjuvant therapies were for-
mally discussed for every patient following the existing
ATA guidelines [4]. We realized that due to the limited
volume of thyroid FNAs performed at pediatric institu-
tions, our cytologists might not have the vast experience
of their adult colleagues. As a quality control measure,
currently all cytology specimens are sent to adult cytolo-
gists at UCSD for review prior to results being released.
The concordance between the second opinion at UCSD
and the initial FNA reading at RCHSD reading is excellent
at 91.7 %.
At an initial glance, our institutional rate of malig-
nancy is quite high in the benign and indeterminate cat-
egories when compared to published data [12]. The
published data in the Bethesda staging system is based
on the adult population with malignancy rate of 5–15 %
[13], whereas in our population more than half of the
nodules removed surgically were malignant. A recent
publication from Boston Children’s hospital reported a
cancer rate of 22 % in their population [14]. However,
majority of their patients (63 %) had benign cytology on
FNA and did not undergo surgery; therefore the false
negative rate of the cytology could not be assessed. In
their indeterminate cytology categories, the cancer rate
is similar to our finding ranging from 40 to 100 % [14]
when compared to final pathology. Despite this discrep-
ancy between the pediatric and adult population, we still
believe that FNA should always be performed prior to
surgery, as recommended in the recently published
pediatric guidelines [3]. Given our excellent institutional
accuracy for “malignant” and “suspicious for malig-
nancy” cytology categories, total thyroidectomy is of-
fered up front for these patients eliminating the need for
a second completion surgery. Two of the three cases of
the false negative FNAs involved large nodules where
the accuracy of FNA may decrease [15]. Based on our
experience and published studies [14], when FNA result
is either benign or indeterminate for nodules ≥ 4 cm, at
a minimum thyroid lobectomy should be strongly con-
sidered, and it is perhaps not unreasonable to consider
total thyroidectomy after careful discussion with the
family presenting pros and cons of each option. Among
the lesions with AUS/FLUS and follicular neoplasm on
FNA, significant numbers (4/10) were follicular variant
of papillary thyroid carcinoma, a diagnosis that is known
to present a challenge with FNA [16].
We observed a significant increase in the number of
malignant cases treated at our institution during the
second half of the study period compared to the first
half. For benign nodules, there was a small increase from
n = 12 (2001–2005) to n = 17 (2006–2010). In compari-
son, there was a 2.75-fold increase in malignant nodules
during that time, from n = 8 (2001–2005) to n = 22
(2006–2010). During the same period, the incidence of
thyroid cancer in the San Diego region increased 1.68-fold
from 7.13/100,000 to 12.31/100,000 according to the Cali-
fornia cancer registry [17] which mirrors the increase in na-
tional incidence according to the SEER database [1]. The
more dramatic increase at our institution may be explained,
in part, by a shift in referral pattern. We speculate that
pediatric patients that previously had been sent to adult
centers with higher thyroid surgical volumes were referred
to RCHSD during the latter portion of the study period. By
establishing a thyroid tumor board where pediatric special-
ists across disciplines meet and discuss management, we
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were able to provide streamlined and standardized care
where guidelines and best practices are closely followed.
We believe that by building a “center of excellence,” we
have attracted more referrals of higher complexity cases
from the community. Most of the national increase in
adults in recent years is generally attributed to early detec-
tion of small T1 nodules due to increased US sensitivity
[18, 19]. However this is not the case with our population.
Figure 1 shows the pathologic staging of all 30 consecutive
cases during the study period between 2001 and 2010.
There is an increase in the number of cases managed at
our institution, and also more aggressive presentation with
T3/T4 lesions, positive nodal and pulmonary metastasis. In
the second half of the study, there were a total of six T3
and two T4 tumors that were not seen during the first half.
All seven patients with N1b disease presented with bulky
neck mass at the initial visit. Among the patients with posi-
tive N1a disease, four patients did have relatively small pri-
mary tumors, three T1 and one T2 nodules. For these four
cases, the performance of the central neck dissection may
have up-staged the patients compared to earlier years
where comprehensive neck dissections were not performed.
These cases may have contributed to the increased overall
staging of the cohort due to surgeon practice or detection
bias.
With regards to surgical complications, we are unable
to report the rate of transient recurrent nerve paralysis
or hypocalcemia in the postoperative period due to lack
of systematic documentation during this long study
period. However, since 2007, all thyroidectomy patients
at our institution are required to have both pre-op and
postop flexible laryngoscopy exam with clear documen-
tation of vocal cord mobility. Protocols are in place now
to document systematically both serum calcium and
PTH level postop and at subsequent outpatient follow-
ups. Future analyses will be able to report on these
points as a measure of surgical outcomes.
Conclusions
There has been a substantial increase in the number of
WDTC cases referred to our institution in recent years
with more advanced TNM staging at the time of initial
presentation. There is a strong female predominance in
a largely Hispanic population. Despite the advanced dis-
ease in some cases, both local regional control and
short-term outcomes are excellent with comprehensive
thyroidectomy surgery, appropriate therapeutic neck dis-
sections followed by adjuvant I-131 and suppressive
levothyroxine therapy.
Finally, long-term follow-up is essential to evaluate ul-
timate prognosis in the treatment of WDTC in pediatric
population with disease specific survival and recurrence
rate measured in decades instead of years. Since most of
our patients present in adolescence, their care often
transitions to adult institutions several years after com-
pletion of their treatment making follow-up data difficult
to obtain, not to mention patient relocation. This is a
challenge faced not only by pediatric specialists, but also
by many adult centers. In order to follow these patients
longitudinally, a national database needs to be estab-
lished where a patient’s records can be carried over insti-
tutions. Secure data sharing and health information
exchange through Electronic Health Records technology
will also be helpful.
We have highlighted some of the challenges in the
management of thyroid nodules and treatment of
WDTC in the pediatric population. The newly published
pediatric guideline for WDTC by the ATA should help
standardize future management and treatment [3].
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